[Skip to Navigation]
Sign In
Views 174
Citations 0
Comment & Response
September 2017

Mutation in BRAF V600E: A Poor Prognostic Marker in Stage III Colon Cancers With Deficient MMR?—Reply

Author Affiliations
  • 1Department of Oncology, Mayo Clinic, Rochester, Minnesota
  • 2Alliance for Clinical Trials in Oncology Statistics and Data Center, Mayo Comprehensive Cancer Center, Rochester, Minnesota
JAMA Oncol. 2017;3(9):1285-1286. doi:10.1001/jamaoncol.2017.1474
Add or change institution
×